Valeant Pharmaceuticals Intl Inc VRX investors may have been surprised yet again Tuesday afternoon as the company announced it received a notice of default from bondholders.
In a press release published at 5 p.m. EDT, Valeant highlighted the notice of default as related to the company's delayed 10-K filing. Valeant said the notice "does not accelerate any of the company's indebtedness" and reassured the 10-K is on schedule to filed on or before the previously disclosed April 29, 2016.
Valeant noted it has until June 11, 2016 to cure the default through the filing of the 10-K.
By the time the official company press release disclosing the notice of default hit newswires, shares of Valeant were already rebounding from after-hours lows. Shortly after Tuesday's closing bell, a Dow Jones report suggested a "big Valeant bond investor Centerbridge notified company of intention to call a default."
Valeant shares last traded at $31.13, down about 2.7 percent from the closing bell.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.